Korys

Korys appeared to be the VC, which was created in 2011. The leading representative office of defined VC is situated in the Huizingen. The venture was found in Europe in Belgium.

We also calculated 8 valuable employees in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Korys, startups are often financed by PMV, Gilde Healthcare, Van Herk Ventures. The meaningful sponsors for the fund in investment in the same round are PMV, Debiopharm Group, Beringea. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, EASME - EU Executive Agency for SMEs.

The higher amount of exits for fund were in 2016. Comparing to the other companies, this Korys performs on 8 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 38 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity.

For fund there is no match between the location of its establishment and the land of its numerous investments - The Netherlands. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Renewable Energy. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Agendia, Amphivena Therapeutics, Greenbyte AB

Notable deals

Review

• No reviews are submitted yet.